2 completed, 1 terminated. 3 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Acrophobia: new trials by email Literature Review of Acrophobia trials Research Report on Acrophobia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intelligent Virtual Reality Therapy System and Testing Its Clinical Efficacy Intelligent Virtual Reality Therapy System (IVRTS) - Phobias, Acrophobia | Phase 1 / Phase 2 | Completed | University College of Medical Sciences, India | 500 | 2018-02-05 | 2020-11-09 |
| Noradrenergic Manipulation and Virtual Reality Exposure Therapy in Phobic Participants Virtual Reality Exposure Therapy (VRET) - Phobic Disorders | Phase 2 / Phase 3 | Completed | VU University of Amsterdam | 56 | 2013-03-01 | 2015-07-08 |
| D-Cycloserine-Enhancer of One-Session Treatment for Phobia of Heights In Vivo Exposure Therapy, Virtual Reality Exposure Therapy, D-Cycloserine - Height Phobia | Phase 2 | Terminated | CAMC Health System | 4 | 2009-07-10 | 2026-10-22 |
Phobic Disorders (2) · Aerophobia (1) · Anxiety Disorders (1)
Mental Disorders (2) · Anxiety Disorders (1)
Virtual Reality Exposure Therapy (2) · Cycloserine (1)
CAMC Health System (1) · University College of Medical Sciences, India (1) · VU University of Amsterdam (1)
India (1) · Netherlands (1) · United States (1)
Cristian Sirbu, Ph.D. (1) · Manjit Singh Bhatia, MBBS; MD (1) · Paul Emmelkamp, PhD (1)
PMID 12296495, PMID 20235773, PMID 21492829, PMID 21639653, PMID 23398031, PMID 26203478, PMID 26833396, PMID 28475502, PMID 30007519, PMID 30696471